What We're Reading: Page 132
Industry reads hand-picked by our editors
Feb 22, 2022
-
Endpoints News
Biopharma has hyped AI for years. But as the first trials get underway, experts try to manage expectations
-
The New York Times
Got a Covid Booster? You Probably Won't Need Another for a Long Time
-
FiercePharma
Roche settles lawsuit claiming AstraZeneca's Ultomiris infringes delivery patent
-
The Boston Globe
Dr. Paul Farmer, who tirelessly brought health care to the world’s neediest, dies at 62
Feb 18, 2022
-
The Wall Street Journal
Lower Omicron Efficacy Delayed FDA Review on Pfizer Shot in Kids Under 5
-
Endpoints News
Amgen quietly kills an obesity program, casting bleak future for once-promising target
-
Generics Bulletin
Revlimid Rivals Launch Across Europe
Feb 17, 2022
-
Associated Press
Biden tapping 2 to step in for ousted science adviser
-
Financial Times
Merck struggles to win European approval for Covid antiviral pill
-
Nature
NIH issues a seismic mandate: share data publicly
-
IEEE Spectrum
Their Bionic Eyes Are Now Obsolete and Unsupported
Feb 16, 2022
Feb 15, 2022
Feb 14, 2022
-
The Financial Times
Moderna in talks to set up UK research and manufacturing
-
Bloomberg
Biotech Money Shock: Investors Unwind Speculative Bets as Pandemic Fears Fade
-
Chemical & Engineering News
Francis Collins on diversity, politics, and his legacy
-
Endpoints News
Eli Lilly and Roche ask CMS not to be lumped in with Aduhelm's restrictive judgment
Previous
